Celsius has almost another 150 million shares which are convertible/exercisable so it's fully diluted market cap is closer to $150 million. It soared on hype (7-11 deal) and momentum players IMHO, but even before that it was valued at $20 to $50 million, also a wild overvaluation, again, IMHO.
Sadly, that does not convince me that DKAM is undervalued in an absolute sense. At the moment, I think the opposite, but I'll give you that it's nowhere near as overvalued as Celsius.
My post however was simply to correct what I think is a wrong calculation PKG is doing about recent share issuance. When the company looks to be headed toward profitability, or positive cash flow (based on results, not speculation), I think $14 million might be a reasonable valuation. But so would $10 million or $20 million, depending on sales and growth rate. I'm not concerned with whether it's getting somewhat diluted these days, in fact, I think using shares to pay bills or get funds at anywhere near the current price is a good move for any company with a working capital deficit.
I'm afraid in my wildest scenarios I can't see a company, let alone one in a consumer product business, going from $14 million to multi-billions in valuation, even in a decade. But if you do, I would suggest aggressive buying and promotion among your friends and relatives.
News 
Market Data 
Discover 
AI
